Demand shift appears to complicate Cristália-Takeda plant deal scrutiny in Brazil
Cristália’s planned acquisition of Takeda’s pharmaceutical plant in Jaguariúna in Brazil is raising questions about how easily pharmaceutical companies could shift outsourced manufacturing away from the facility, highlighting a layer of...To view the full article, register now.
Already a subscriber? Click here to view full article